Chargement en cours...

The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy

Hepatocellular carcinoma (HCC) is a primary concern for patients with chronic hepatitis B (CHB). Antiviral therapy has been reasonably the focus of interest for HCC prevention, with most studies reporting on the role of the chronologically preceding agents, interferon-alfa and lamivudine. The impact...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Mol Hepatol
Auteurs principaux: Varbobitis, Ioannis, Papatheodoridis, George V.
Format: Artigo
Langue:Inglês
Publié: The Korean Association for the Study of the Liver 2016
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5066383/
https://ncbi.nlm.nih.gov/pubmed/27729632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2016.0045
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!